Cyclosporin A Suppresses ICAM-1 Expression by Papillary Endothelium in Healing Psoriatic Plaques
Open Access
- 1 March 1991
- journal article
- clinical trial
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 96 (3), 362-369
- https://doi.org/10.1111/1523-1747.ep12465404
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Intralesional cyclosporin in psoriasis: effects on T lymphocyte and dendritic cell subpopulationsBritish Journal of Dermatology, 2006
- Intralesional cyclosporine in the treatment of psoriasis: A clinical, immunologic, and pharmacokinetic studyJournal of the American Academy of Dermatology, 1990
- Cyclosporin, Calmodulin, PsoriasisJournal of Investigative Dermatology, 1989
- CD Antigens 1989International Journal of Cancer, 1989
- Intercellular adhesion molecule-1 (ICAM-1) expression correlated to inflammationBritish Journal of Dermatology, 1989
- Long-term cyclosporin for psoriasisBritish Journal of Dermatology, 1989
- Immunologic mechanisms in psoriasisJournal of the American Academy of Dermatology, 1988
- Low-dose cyclosporin A in severe psoriasis. A double-blind studyBritish Journal of Dermatology, 1988
- Psoriasis: a disease of abnormal Keratinocyte proliferation induced by T lymphocytesImmunology Today, 1986
- Langerhans Cells in Skin from Patients with Psoriasis: Quantitative and Qualitative Study of T6 and HLA-DR Antigen-Expressing Cells and Changes with Aromatic Retinoid AdministrationJournal of Investigative Dermatology, 1983